[1]. Dong, B., et al., Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis. J Thorac Dis, 2020. 12(10): p. 5934-5954.
[2]. Dong, B., et al., Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching. Radiat Oncol, 2019. 14(1): p. 195.
[3]. Chang, J.Y., et al., Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol, 2015. 16(6): p. 630-7.
[4]. Endo, C., et al., Results of long-term follow-up of patients with completely resected non-small cell lung cancer. Ann Thorac Surg, 2012. 93(4): p. 1061-8.
[5]. Lou, F., et al., Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg, 2013. 145(1): p. 75-81; discussion 81-2.
[6]. al-Kattan, K., et al., Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg, 1997. 12(3): p. 380-4.
[7]. Erhunmwunsee, L. and B.C. Tong, Preoperative Evaluation and Indications for Pulmonary Metastasectomy. Thorac Surg Clin, 2016. 26(1): p. 7-12.
[8]. Petrella, F., et al., Which factors affect pulmonary function after lung metastasectomy? Eur J Cardiothorac Surg, 2009. 35(5): p. 792-6.
[9]. Chinese Medical Association Radiation Oncology Therapy Branch, Chinese Anti-Cancer Association Oncology Radiation Therapy Professional Committee, and Chinese Medical Doctor Association Radiation Therapist Branch, Chinese Expert Consensus on Stereotactic Radiotherapy for Early Non-small Cell Lung Cancer (2019 Edition)
Chinese expert consensus on stereotactic body radiation therapy for early stage non-small cell lung cancer (2019 Edition) %J 中华肿瘤杂志 %J Chinese Journal of Oncology. 2020. 42(7): p. 522-530.
[10]. Liu Lunxu, et al., Consensus of Chinese Thoracic Surgery Experts on Follow-up of Non-Small Cell Lung Cancer
Chinese thoracic surgery experts consensus on postoperative follow-up plans for non-small cell lung cancer patients %J 中国胸心血管外科临床杂志 %J Chinese Journal of Clinical Thoracic and Cardiovascular Surgery. 2021. 28(1): p. 4-10.
[11]. Caulo, A., et al., Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria. Eur Radiol, 2012. 22(3): p. 588-606.
[12]. Keidar, Z., et al., PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med, 2004. 45(10): p. 1640-6.
[13]. Pfannschmidt, J., et al., Surgical intervention for pulmonary metastases. Dtsch Arztebl Int, 2012. 109(40): p. 645-51.
[14]. Corona-Cruz, J.F., et al., Lung metastasectomy: long-term outcomes in an 18-year cohort from a single center. Surg Oncol, 2012. 21(3): p. 237-44.
[15]. Jang, J.W., et al., Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Int J Radiat Oncol Biol Phys, 2009. 74(2): p. 412-8.
[16]. Lewis, S.L., et al., Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists. Am J Clin Oncol, 2017. 40(4): p. 418-422.
[17]. Widder, J., et al., Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? Radiother Oncol, 2013. 107(3): p. 409-13.
[18]. Miyazaki, T., et al., Surgery or stereotactic body radiotherapy for metachronous primary lung cancer? A propensity score matching analysis. Gen Thorac Cardiovasc Surg, 2020. 68(11): p. 1305-1311.
[19]. Rieber, J., et al., Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy". Lung Cancer, 2016. 97: p. 51-8.
[20]. Onishi, H., et al., Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer, 2004. 101(7): p. 1623-31.
[21]. Timmerman, R., et al., Stereotactic body radiation therapy for inoperable early stage lung cancer. Jama, 2010. 303(11): p. 1070-6.
[22]. Nagata, Y., et al., Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys, 2015. 93(5): p. 989-96.
[23]. Crabtree, T.D., et al., Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 2010. 140(2): p. 377-86.
[24]. Senthi, S., et al., Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Lancet Oncol, 2012. 13(8): p. 802-9.
[25]. Sun, B., et al., Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial. J Thorac Oncol, 2017. 12(6): p. 983-992.
[26]. Lagerwaard, F.J., et al., Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys, 2012. 83(1): p. 348-53.
[27]. Martini, N. and M.R. Melamed, Multiple primary lung cancers. J Thorac Cardiovasc Surg, 1975. 70(4): p. 606-12.
[28]. Rieber, J., et al., Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease. Int J Radiat Oncol Biol Phys, 2017. 98(3): p. 511-520.
[29]. Huang, K., et al., Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature. Radiother Oncol, 2012. 102(3): p. 335-42.
[30]. Mohammed, N., et al., Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors. Radiother Oncol, 2011. 99(1): p. 18-22.